Cargando…
Oncolytic Viral Therapy for Glioma by Recombinant Sindbis Virus
SIMPLE SUMMARY: Gliomas account for 27% of all primary central nervous system tumors and have a highly aggressive growth pattern, leading most patients to be insensitive to conventional treatment. Viotherapy as a progressive therapeutic tool may be beneficial to improve the outcome of brain tumor tr...
Autores principales: | Sun, Kangyixin, Shi, Xiangwei, Li, Li, Nie, Xiupeng, Xu, Lin, Jia, Fan, Xu, Fuqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571546/ https://www.ncbi.nlm.nih.gov/pubmed/37835433 http://dx.doi.org/10.3390/cancers15194738 |
Ejemplares similares
-
The G285S mutation in nsP1 is sufficient to render Sindbis virus as a stable vector for gene delivery
por: Shi, Xiangwei, et al.
Publicado: (2023) -
Oncolytic activity of Sindbis virus in human oral squamous carcinoma cells
por: Saito, K, et al.
Publicado: (2009) -
Enhanced Specific Delivery and Targeting of Oncolytic Sindbis Viral Vectors by Modulating Vascular Leakiness in Tumor
por: Tseng, Jen-Chieh, et al.
Publicado: (2009) -
A new anterograde trans-synaptic tracer based on Sindbis virus
por: Shi, Xiang-Wei, et al.
Publicado: (2022) -
The Effects of Sindbis Viral Vectors on Neuronal Function
por: Uyaniker, Seçil, et al.
Publicado: (2019)